Journal article
Disparities in antihypertensive prescribing after stroke linked data from the australian stroke clinical registry
LL Dalli, J Kim, AG Thrift, NE Andrew, NA Lannin, CS Anderson, R Grimley, JM Katzenellenbogen, J Boyd, RI Lindley, M Pollack, M Jude, R Durairaj, D Shah, DA Cadilhac, MF Kilkenny
Stroke | LIPPINCOTT WILLIAMS & WILKINS | Published : 2019
Abstract
Background and Purpose-Despite evidence to support the prescription of antihypertensive medications before hospitaldischarge to promote medication adherence and prevent recurrent events, many patients with stroke miss out on thesemedications at discharge. We aimed to examine patient, clinical, and system-level differences in the prescription ofantihypertensive medications at hospital discharge after stroke.Methods-Adults with acute ischemic stroke or intracerebral hemorrhage alive at discharge were included (years 2009-2013)from 39 hospitals participating in the Australian Stroke Clinical Registry. Patient comorbidities were identified using theInternational Statistical Classification of Dis..
View full abstractGrants
Awarded by Queensland Health
Funding Acknowledgements
This study was funded by a National Health and Medical Research Council (NHMRC) partnership grant (1034415), cofunded by Queensland Health, Monash University, Heart Foundation and Stroke Foundation. The Australian Stroke Clinical Registry (AuSCR) received funding from a range of government, nongovernment, and industry sources. L.L. Dalli is supported by an Australian Government Research Training Program Scholarship. The following authors receive research fellowship support from the NHMRC: Professors Thrift (1042600), Lannin (1112158 cofunded by Heart Foundation), Anderson, Lannin (1112158 cofunded by Heart Foundation), Anderson (1081356), Cadilhac (1154273 cofunded by Heart Foundation); Drs Andrew (1072053), Katzenellenbogen (100807), Kilkenny (1109426).